Implementing Partner:
Project name:
Developing tools to diagnose Canine Distemper Virus in big cats
Location:
Developed in the UK in the University of Kent. Validation will be undertaken at a range of different locations, including Malaysia and Nepal.
Goal:
To develop a reliable and accessible test for detecting canine distemper virus (CDV) antibodies in tigers and other wild carnivores. This test will be validated against the current gold-standard method using at least 100 stored samples from different species, with trials conducted in the UK, Malaysia, and Nepal. By December 2025, they aim to complete development and begin field validation. Full testing will be completed by June 2026, with results published in an open-access scientific journal by December 2026.
- Objective 1: By April 2025, they will have tested six different protein materials to determine which ones are most effective in detecting canine distemper virus (CDV) antibodies, identifying at least one or two promising options for further development.
- Objective 2: By May 2025, they will have developed the first version of the CDV test, confirming that the selected protein material can be placed on a test plate and successfully detect the presence or absence of CDV antibodies in animal blood samples.
- Objective 3: By December 2025, they will have validated the test by trialling it on at least 100 stored animal blood samples from different species, both in the UK and at conservation sites overseas, ensuring that it works accurately and reliably.
- Objective 4: By September 2026, they will have shared our findings with the conservation and scientific community through donor reports, publication in a peer-reviewed open-access journal, and media coverage, making the results accessible for use in wildlife disease monitoring and protection efforts.








